[{"id":"bfc52fa9-4680-4fa9-b43a-67749b5d988e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05739227","created_at":"2023-02-22T15:01:08.202Z","updated_at":"2024-07-02T16:35:54.972Z","phase":"Phase 1","brief_title":"Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies","source_id_and_acronym":"NCT05739227","lead_sponsor":"Xuzhou Medical University","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JD001"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 03/01/2023","start_date":" 03/01/2023","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 05/01/2025","study_completion_date":" 05/01/2025","last_update_posted":"2023-02-22"}]